Aquestive Therapeutics Inc. (AQST) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Join SI Premium – FREE
Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.09 million versus the consensus estimate of $12.45 million.
For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
- Huntington Ingalls wins $418M Navy contract
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
